Hepatitis B and C in liver transplantation: new strategies to combat the enemies.

about

Prophylaxis against Recurrence in Liver Transplantation Patients with Hepatitis B Virus: What is New?TH9 cell differentiation, transcriptional control and function in inflammation, autoimmune diseases and cancer.

P2860

Q26781880-5BEC51E4-721F-418B-9FA4-2C6CA145CD2E Q37688655-89359C09-B756-4EA0-A2C6-97CC6F89C29C

P2860

Hepatitis B and C in liver transplantation: new strategies to combat the enemies.

Item

http://www.wikidata.org/entity/Q38067343

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Hepatitis B and C in liver transplantation: new strategies to combat the enemies.

@en

type

Item

label

Hepatitis B and C in liver transplantation: new strategies to combat the enemies.

@en

prefLabel

Hepatitis B and C in liver transplantation: new strategies to combat the enemies.

@en

P1476

Hepatitis B and C in liver transplantation: new strategies to combat the enemies.

@en

P2093

Iyad Kabar

http://www.w3.org/2001/XMLSchema#string

Susanne Beckebaum

http://www.w3.org/2001/XMLSchema#string

Vito R Cicinnati

http://www.w3.org/2001/XMLSchema#string

P2860

Antiviral prophylactic intervention for chronic hepatitis C virus in patients undergoing liver transplantation

Boceprevir for previously treated chronic HCV genotype 1 infection

Telaprevir for retreatment of HCV infection

Telaprevir for previously untreated chronic hepatitis C virus infection

Boceprevir for untreated chronic HCV genotype 1 infection

Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.

A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation.

An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.

Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.

Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis.

P304

172-193

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1002/RMV.1734

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23239274

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation

Hepatitis B and C in liver transplantation: new strategies to combat the enemies.

about

P2860

P2860

Hepatitis B and C in liver transplantation: new strategies to combat the enemies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921